Aspire Biopharma (ASBP) Institutional Ownership $0.36 +0.01 (+1.42%) As of 04:00 PM Eastern Add Compare Share Share Ownership Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesOwnershipSEC FilingsShort InterestTrendsBuy This Stock Institutional Ownership Changes (13F Filings) for Aspire Biopharma (NASDAQ:ASBP)CurrentInstitutional OwnershipPercentage19.17%Number ofInstitutional Buyers(last 12 months)4TotalInstitutional Inflows(last 12 months)$302.23KNumber ofInstitutional Sellers(last 12 months)0 Get ASBP Insider Trade Alerts Want to know when executives and insiders are buying or selling Aspire Biopharma stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Aspire Biopharma Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails8/14/2025Jane Street Group LLC152,552$41K0.0%+625.8%0.308% 8/5/2025Optivise Advisory Services LLC235,106$63K0.0%+120.9%0.475% 7/30/2025Crewe Advisors LLC626,854$169K0.0%+100.0%1.266% 7/9/2025Procyon Advisors LLC648,411$174K0.0%+558.3%1.309% (Data available from 1/1/2016 forward) ASBP Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of ASBP shares? During the previous two years, the following institutional investors and hedge funds held shares of Aspire Biopharma shares: Procyon Advisors LLC ($174K), Crewe Advisors LLC ($169K), and Optivise Advisory Services LLC ($63K), Jane Street Group LLC ($41K).Learn more on Aspire Biopharma's institutional investors. What percentage of Aspire Biopharma's stock is owned by institutional investors? 19.17% of Aspire Biopharma's stock is owned by institutional investors. Learn more on ASBP's institutional investor holdings. Which institutional investors have been buying Aspire Biopharma's stock? The following institutional investors have purchased Aspire Biopharma's stock in the last 24 months: Procyon Advisors LLC ($549.91K), Crewe Advisors LLC ($313.43K), Jane Street Group LLC ($131.53K), and Optivise Advisory Services LLC ($128.66K). How much institutional buying is happening at Aspire Biopharma? Institutional investors have bought a total of 1,123,531 shares in the last 24 months. This purchase volume represents approximately $302.23K in transactions. Related Companies ATYR Major Shareholders ARTV Major Shareholders ABVC Major Shareholders BYSI Major Shareholders QNTM Major Shareholders VNRX Major Shareholders GANX Major Shareholders INKT Major Shareholders NRXP Major Shareholders DTIL Major Shareholders This page (NASDAQ:ASBP) was last updated on 10/8/2025 by MarketBeat.com Staff From Our PartnersStunning new initiative unfolding in the White House?what I just learned about what’s unfolding in the White House is truly stunning… And you need to see it for...Paradigm Press | SponsoredIf You Keep Cash In A U.S. Bank Account… Read This NOWThe Treasury Department just issued a stunning warning: U.S. banks could lose up to $6.6 trillion of custom...Banyan Hill Publishing | Sponsored"I'm risking my reputation on this"If I'm right about what's coming, this could be the most important book you'll read this yearCrypto 101 Media | SponsoredForget AI, This Will Be the Next Big Tech BreakthroughAfter picking Nvidia in 2016, before it jumped 27,000%... Jeff Brown is back with what he believes will be ...Brownstone Research | Sponsored1 Hour Once A DayMy top income trading expert, Dave Aquino, just released a 1-hour trading strategy designed specifically to he...Base Camp Trading | SponsoredClaim Your Share of $5.39 BILLION in AI Equity ChecksThe U.S. government just took advantage of Public Law 81-774 to crack down on AI companies... In turn, enfo...Angel Publishing | SponsoredGOLD ALERTGold has shattered records, soaring past $3,800 an ounce... But Stansberry Senior Partner Dr. David "Doc" E...Stansberry Research | SponsoredThe Robotics Revolution has arrived … and one $7 stock could take off as a result.Something big is brewing in Washington. According to my research, an executive order from President Trump c...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Aspire Biopharma Holdings, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Aspire Biopharma With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
